findmyKOL
Clinical trialNCT02357810CompletedPhase 2Interventional

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

SponsorNorthwestern UniversityEnrollment178Adult LiposarcomaMetastatic LiposarcomaMetastatic OsteosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent LiposarcomaRecurrent Osteosarcoma+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Northwestern University- Lake Forest Hospital

    Lake Forest, Illinois, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • Masonic Cancer Center, University of Minnesota

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Mar 2015
Primary completion
27 Apr 2018
Completion
12 Oct 2021
Last update posted
7 Jun 2022
Registered enrollment
178
Registry id
NCT02357810

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.